Clinical monitoring can account for up to 50% of study costs. IQVIA's clinical monitoring solutions integrate technology, data, analytics, and expert knowledge to create flexible, customized solutions that can reduce the cost of trial oversight by up to 25% - all while improving operations.
IQVIA's Risk-Based Monitoring (RBM) is proven to drive faster access to high quality data. With predictive and advanced analytics, you can identify and address issues earlier, creating efficiencies and improving safety for patients. Additional benefits include
It takes both experience and technology to effectively maximize risk-based monitoring. Our centrally located clinical monitors continuously review and analyze data, including a subject-level review process, to deliver insights that identify and mitigate risks across sites and patients as well as the study itself.
IQVIA's centralized monitoring platform powers a more efficient approach to risk management by using automated workflows, resulting in
Combining risk-based and centralized monitoring enables subject-level surveillance and improves patient safety. Targeted site support enhances CRA efficiency. And the combination yields measurable improvements in outcomes.
Navigate complex regulatory requirements with expert insights and bring transparency, efficiency and predictability to your regulatory affairs strategy.
Use AI, machine learning, NLP and new technologies to streamline pharmacovigilance, improve efficiencies, reduce costs, and meet safety demands.